Impact of immortal person-time and time scale in comparative effectiveness research for medical devices: A case for implantable cardioverter-defibrillators

Journal of Clinical Epidemiology

Volumn 66, Issue 8 SUPPL.8, 2013, Pages

  Mi, Xiaojuan ^a   Hammill, Bradley G ^a   Curtis, Lesley H ^a,b   Greiner, Melissa A ^a   Setoguchi, Soko ^a,b  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bias (epidemiology); Defibrillators, implantable; Heart failure; Immortal time; Landmark method; Mantel Byar method; Propensity score; Regression analysis; Time scale

Indexed keywords

AGED; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL RESEARCH; COHORT ANALYSIS; COMPARATIVE EFFECTIVENESS; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEDICARE; PRIORITY JOURNAL; REGISTER; RETROSPECTIVE STUDY; SYSTEMATIC ERROR; TIME; VALIDITY;

BIAS (EPIDEMIOLOGY); DEFIBRILLATORS, IMPLANTABLE; HEART FAILURE; IMMORTAL TIME; LANDMARK METHOD; MANTEL-BYAR METHOD; PROPENSITY SCORE; REGRESSION ANALYSIS; TIME SCALE;

AGED; BIAS (EPIDEMIOLOGY); COMPARATIVE EFFECTIVENESS RESEARCH; DATA INTERPRETATION, STATISTICAL; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEART FAILURE; HUMANS; MALE; MEDICARE; PROBABILITY; REGISTRIES; TIME FACTORS; TIME-TO-TREATMENT; UNITED STATES;

EID: 84880223045     PISSN: 08954356     EISSN: 18785921     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2013.01.014     Document Type: Article

References (29)

1. S. Suissa Immortal time bias in pharmacoepidemiology Am J Epidemiol 167 2008 492 499 (Pubitemid 351264145)
2. A.M. Walker Observation and inference: an introduction to the methods of epidemiology 1991 Epidemiology Resources, Inc. Newton Lower Falls, MA
3. L.E. Levesque, J.A. Hanley, A. Kezouh, and S. Suissa Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes BMJ 340 2010 b5087
4. C. Renoux, and S. Suissa Immortal time bias in the study of effectiveness of interferon-beta in multiple sclerosis Ann Neurol 64 2008 109 110
5. S. Suissa Immortal time bias in observational studies of drug effects Pharmacoepidemiol Drug Saf 16 2007 241 249 (Pubitemid 46431687)
6. S. Suissa Effectiveness of inhaled corticosteroids in chronic obstructive pulmonary disease: immortal time bias in observational studies Am J Respir Crit Care Med 168 2003 49 53 (Pubitemid 37046632)
7. N. Mantel, and D.P. Byar Evaluation of response-time data involving transient states: an illustration using heart-transplant data J Am Stat Assoc 69 1974 81 86
8. J. Anderson, K. Cain, and R. Gelber Analysis of survival by tumor response J Clin Oncol 1 1983 710 719 (Pubitemid 14202071)
9. K.J. Rothman, S. Greenland, and T.L. Lash Modern epidemiology 3rd ed. 2008 Wolters Kluwer Health/Lippincott Williams & Wilkins Philadelphia, PA
10. B.G. Hammill, L.H. Curtis, K.A. Schulman, and D.J. Whellan Relationship between cardiac rehabilitation and long-term risks of death and myocardial infarction among elderly Medicare beneficiaries Circulation 121 2010 63 70
11. A.F. Hernandez, G.C. Fonarow, B.G. Hammill, S.M. Al-Khatib, C.W. Yancy, and C.M. O'Connor Clinical effectiveness of implantable cardioverter- defibrillators among Medicare beneficiaries with heart failure Circ Heart Fail 3 2010 7 13
12. S. Setoguchi, R.J. Glynn, J. Avorn, M.A. Mittleman, R. Levin, and W.C. Winkelmayer Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis J Am Coll Cardiol 51 2008 1247 1254 (Pubitemid 351400891)
13. S. Setoguchi, R.J. Glynn, J. Avorn, H. Mogun, and S. Schneeweiss Statins and the risk of lung, breast, and colorectal cancer in the elderly Circulation 115 2007 27 33 (Pubitemid 46058608)
14. S. Setoguchi, L.W. Stevenson, and S. Schneeweiss Repeated hospitalizations predict mortality in the community population with heart failure Am Heart J 154 2007 260 266 (Pubitemid 47079017)
15. P.S. Chan, B.K. Nallamothu, J.A. Spertus, F.A. Masoudi, C. Bartone, and D.J. Kereiakes Impact of age and medical comorbidity on the effectiveness of implantable cardioverter-defibrillators for primary prevention Circ Cardiovasc Qual Outcomes 2 2009 16 24
16. S.K. James, U. Stenestrand, J. Lindbäck, J. Carlsson, F. Scherstén, T. Nilsson SCAAR Study Group Long-term safety and efficacy of drug-eluting versus bare-metal stents in Sweden N Engl J Med 360 2009 1933 1945
17. E.L. Korn, B.I. Graubard, and D. Midthune Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale Am J Epidemiol 145 1997 72 80 (Pubitemid 27009060)
18. A.C.M. Thiébaut, and J. Bénichou Choice of time-scale in Cox's model analysis of epidemiologic cohort data: a simulation study Stat Med 23 2004 3803 3820 (Pubitemid 40074078)
19. G.H. Bardy, K.L. Lee, D.B. Mark, J.E. Poole, D.L. Packer, R. Boineau Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 2005 225 237 (Pubitemid 40110811)
20. A.J. Moss, W. Zareba, W.J. Hall, H. Klein, D.J. Wilber, D.S. Cannom Multicenter Automatic Defibrillator Implantation Trial II Investigators Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med 346 2002 877 883 (Pubitemid 34984635)
21. G.C. Fonarow, W.T. Abraham, N.M. Albert, W.A. Gattis, M. Gheorghiade, and B. Greenberg Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design Am Heart J 148 2004 43 51 (Pubitemid 38900479)
22. B.G. Hammill, A.F. Hernandez, E.D. Peterson, G.C. Fonarow, K.A. Schulman, and L.H. Curtis Linking inpatient clinical registry data to Medicare claims data using indirect identifiers Am Heart J 157 2009 995 1000
23. S. Schneeweiss, J.A. Rassen, R.J. Glynn, J. Avorn, H. Mogun, and M.A. Brookhart High-dimensional propensity score adjustment in studies of treatment effects using health care claims data Epidemiology 20 2009 512 522
24. S.R. Cole, and M.A. Hernan Adjusted survival curves with inverse probability weights Comput Methods Programs Biomed 75 2004 45 49 (Pubitemid 38648876)
25. R.P. Laubender, and R. Bender Estimating adjusted risk difference (RD) and number needed to treat (NNT) measures in the Cox regression model Stat Med 29 2010 851 859
26. S.S. Dhruva, and R.F. Redberg Variations between clinical trial participants and Medicare beneficiaries in evidence used for Medicare national coverage decisions Arch Intern Med 168 2008 136 140 (Pubitemid 351185879)
27. S. Setoguchi, A. Nohria, J.A. Rassen, L.W. Stevenson, and S. Schneeweiss Maximum potential benefit of implantable defibrillators in preventing sudden death after hospital admission because of heart failure CMAJ 180 2009 611 616
28. R.F. Redberg Disparities in use of implantable cardioverter- defibrillators: moving beyond process measures to outcomes data J Am Med Assoc 298 2007 1564 1566 (Pubitemid 47529391)
29. J. Liu, E.D. Weinhandl, D.T. Gilbertson, A.J. Collins, and W.L. St Peter Issues regarding 'immortal time' in the analysis of the treatment effects in observational studies Kidney Int 81 2012 341 350